SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125282-05-002434
Filing Date
2005-05-10
Accepted
2005-05-10 17:24:43
Documents
5
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT b406582_10q.txt 10-Q 178417
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b406582ex31_1.txt EX-31.1 4202
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b406582ex31_2.txt EX-31.2 4262
4 STATEMENT PURSUANT TO 18 U.S.C. SECTION 1350 b406582ex32_1.txt EX-32.1 1014
5 STATEMENT PURSUANT TO 18 U.S.C. SECTION 1350 b406582ex32_2.txt EX-32.2 1076
  Complete submission text file 0001125282-05-002434.txt   190484
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15313 | Film No.: 05818029
SIC: 2833 Medicinal Chemicals & Botanical Products